3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Neoplasm Metastasis
2
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Melanoma
1
Lymphatic Metastasis
1
Head and Neck Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 10
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Interventions
Gemcitabine
19
130-nm albumin-bound paclitaxel
16
Specimen Handling
15
Magnetic Resonance Spectroscopy
10
Irinotecan
10
Fluorouracil
9
Biopsy
9
Leucovorin
8
pembrolizumab
7
Oxaliplatin
7
Cyclophosphamide
7
fludarabine
6
Cisplatin
5
Pemetrexed
4
Cetuximab
4
Albumin-Bound Paclitaxel
4
zimberelimab
3
trastuzumab deruxtecan
3
olaparib
3
irinotecan sucrosofate
3
durvalumab
3
dehydroftorafur
3
aldesleukin
3
Taxes
3
Radiosurgery
3
Nivolumab
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
veliparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
avelumab
×
30 days
×
Clear all
No trials found.